Over the last, I'm going to say, 15 years, what we've seen at Health Canada in terms of what we call postmarket oversight—inspection, in plain language—is a gradual ramp-up. In and around the time when the report that's being cited would have come out, there was little activity, and it was more reactive than proactive.
What we've seen, though, over the last eight or nine years is a solid ramp-up. By that I mean starting with very time-specific and small inspection-like projects, to an inspection pilot a couple of years ago in response to the Auditor General's report, and now an interim inspection approach whereby we're trying to keep momentum going until such time as we can fund a more permanent inspection program.